AVDL
Avadel Pharmaceuticals
AVDL
AVDL
74 hedge funds and large institutions have $293M invested in Avadel Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
32% more funds holding
Funds holding: 56 → 74 (+18)
9.18% less ownership
Funds ownership: 71.59% → 62.4% (-9.2%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
74
Holding in Top 10
3
Calls
$7.34M
Puts
$4.11M
Top Buyers
| 1 | +$25.3M | |
| 2 | +$24.1M | |
| 3 | +$5.58M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$5.23M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$4.31M |
Top Sellers
| 1 | -$7.45M | |
| 2 | -$3.9M | |
| 3 | -$2.69M | |
| 4 |
Goldman Sachs
New York
|
-$1.52M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.3M |